Form 483

Seoul Cosmetics Co., Ltd. Form 483, 2023-02-03

FDA issued a Form 483 to Seoul Cosmetics Co., Ltd. on 2023-02-03 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Seoul Cosmetics Co., Ltd. · Namdong, Korea (the Republic of) · Issued February 3, 2023

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Feb 2023
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Michael H Tollon

3 Feb 2023
21 CFR 211.110(a)

Written in-process control procedures

Cited by Michael H Tollon

3 Feb 2023
21 CFR 211.165(e)

Test methods

Cited by Michael H Tollon

3 Feb 2023
21 CFR 211.166(b)

Adequate number of batches on stability

Cited by Michael H Tollon

3 Feb 2023
21 CFR 211.63

Equipment Design, Size and Location

Cited by Michael H Tollon

Inspected site

SCSeoul Cosmetics Co., Ltd.Namdong, Korea (the Republic of)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(b)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere